Skip to main content
Equibles
ACXP logo

ACXP · Acurx Pharmaceuticals, Inc. · Suppliers & Customers

Track ACXP — free

Use ACXP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACXP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.99 -0.05 (-4.37%) At close · Nov 12 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Aug 13, 2026
Market Cap
$5.97M
Shares
6.06M
Volume · Nov 12 159.19K Avg daily vol (3M) 124.59K

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones ACXP names, and the companies that name ACXP.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who ACXP sells to, buys from and competes with

  • 1 supplier
  • 0 customers
  • 2 competitors

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1736243 CUSIP 00510M203 13F (30d) 10 filings 10 filers Visit website Investor relations